Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProAir Digihaler in COPD Disease Management: A Real World Study to Assess ProAir Digihaler Inhalation Parameters Thresholds and Their Use to Identify Deterioration in Clinical Practice

NCT04821869 is registered in ClinicalTrials.gov with Pulmonary Research Institute of Southeast Michigan as lead sponsor.

NCT NCT04821869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProAir Digihaler in COPD Disease Management: A Real World Study to Assess ProAir Digihaler Inhalation Parameters Thresholds and Their Use to Identify Deterioration in Clinical Practice
Lead sponsor
Pulmonary Research Institute of Southeast Michigan
Phase
Observational
Overall status
Completed
Start date
May 10, 2021
Completion date
June 21, 2022
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, copd exacerbation acute